Parallel distribution definition
Parallel distribution means pressure or gravity distribution of effluent that proportionally and simultaneously loads multiple sections of a treatment and/or dispersal component.
Parallel distribution means the distribution of effluent that proportionally loads multiple sections of a dispersal field at one time.
Parallel distribution means the distribution of effluent that proportionally loads multiple sections
More Definitions of Parallel distribution
Parallel distribution means a dispersal field in which the OWTS effluent is distributed simultaneously through a distribution box.
Parallel distribution means distribution from one Member State to another of a veterinary medicinal product authorised under a centralised procedure by an establishment authorised as referred to in Article 105 which is independent of the holder of the marketing authorisation.
Parallel distribution means the importation from a Member State or a country within the European Economic Area of a centrally authorised medicinal product, by an importer who is someone other than the importer authorised and appointed by the marketing authorisation holder of the product on the Maltese market;
Parallel distribution. Programme: yearly sampling and testing programme performed on Centrally Authorised Products that are subject to parallel distribution. Each year a number of Centrally Authorised Products will be randomly sampled from the parallel distribution chain and tested. ▪ Ad Hoc API Programme: yearly sampling and testing programme performed on Active Pharmaceutical Ingredients upon request by a member state or EMA whenever samples are available from a manufacturing site where there is a suspicion of GMP non-compliance.
Parallel distribution. Programme: yearly programme performed on Centrally Authorised Products that are subject to parallel distribution. Each year a number of Centrally Authorised Products will be selected by the EMA in collaboration with the Council/EDQM and sampled from the parallel distribution chain. The label check will be performed on site and the authenticity of the sample will be verified by means of the scanning of the unique identifier, where possible. No testing of the finished product will be performed unless there are concerns raised on the authenticity of the product. If testing is required, the rates applicable to product testing activity will be applied. − Nitrosamines Programme: the purpose of this yearly programme is to test for nitrosamines presence in human medicinal products (finished product) selected on a risk based approach and randomly. The risk based product selection of this programme should be agreed between EMA, Council/EDQM and the CAP Advisory Group. If needed, other experts may be consulted for input.